Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-15-083598

Sr VP/Chief Commercial Officer acquired 1,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cearnal Martin E Sr VP/Chief Commercial Officer 2015-12-02 Grant or award +1,950 $5.58 $10,881 131,856 D
Loading xslF345X03/doc4.xml…